Try our beta test site
21 studies found for:    Schilder's Disease
Show Display Options
Rank Status Study
21 Completed Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: irofulven

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-21) Next Page   
Study has passed its completion date and status has not been verified in more than two years.